Docetaxel in Non Small Cell Lung Cancer (NSCLC)

NCT00432315 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi